Healthpeak Undertakes Significant Share Buyback Initiative in 2025

Healthpeak Properties Inc (DOC) undertook a significant share buyback in 2025, acquiring 3.9 million shares at an average price of $18.22 each for $72 million. The company had approximately $406 million left for further buybacks as part of the ongoing program. Analysts forecast an average target price of $21.85 with a high estimate of $26.00 and a low estimate of $18.00, indicating an upside of 15.77% from the current price.

Healthpeak Properties Inc. (DOC) has undertaken a significant share buyback initiative in 2025, demonstrating a strong commitment to returning value to its shareholders. The company acquired 3.9 million shares at an average price of $18.22 each, totaling an expenditure of $72 million. By late July of the same year, Healthpeak still had approximately $406 million available for further buybacks as part of the ongoing program [3].

Analysts have forecasted an average target price of $21.85 for Healthpeak Properties Inc. (DOC), with a high estimate of $26.00 and a low estimate of $18.00. This indicates an upside of 15.77% from the current price of $18.87 [3]. The consensus recommendation from 17 brokerage firms is currently "Outperform," with an average brokerage recommendation of 2.2 out of 5 [3].

In Q2 2025, Healthpeak reported earnings of $31.7 million, or 5 cents per share, down from $146 million, or 21 cents per share, in the prior-year period. The company also revised its earnings per-share forecast for the year downward to between 25 cents and 31 cents from prior guidance in the range of 30 cents to 36 cents [2]. The stock declined by 6.5% following these announcements, trading around $17.64, marking its largest percentage decrease since March 10, 2023 [2].

Healthpeak's strategic focus in Q2 2025 included internalizing property management, expanding AI capabilities, and enhancing outpatient developments. The company's CCRC business generated approximately $200 million of annual NOI with occupancy at 86%, while the outpatient medical segment reported near record levels of same-store growth, retention, and re-leasing spreads [1]. Despite challenges in the lab segment, management maintained a diversified portfolio and positive leading indicators, expressing confidence in the company's long-term prospects.

References:
[1] https://seekingalpha.com/news/4472401-healthpeak-anticipates-ccrc-same-store-growth-to-exceed-guidance-high-end-while-expanding-ai
[2] https://www.marketwatch.com/story/healthpeak-properties-shares-decline-on-lower-2q-profit-guidance-revision-616bfa78
[3] https://www.gurufocus.com/news/3003259/healthpeak-doc-undertakes-significant-share-buyback-in-2025-doc-stock-news